- Home
- AXSM vs HLNE Comparison
AXSM vs HLNE Comparison
Compare AXSM & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- HLNE
- Stock Information
- Founded
- AXSM 2012
- HLNE 1991
- Country
- AXSM United States
- HLNE United States
- Employees
- AXSM N/A
- HLNE N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- HLNE Investment Managers
- Sector
- AXSM Health Care
- HLNE Finance
- Exchange
- AXSM Nasdaq
- HLNE Nasdaq
- Market Cap
- AXSM 5.1B
- HLNE 5.9B
- IPO Year
- AXSM 2015
- HLNE 2017
- Fundamental
- Price
- AXSM $110.12
- HLNE $145.72
- Analyst Decision
- AXSM Strong Buy
- HLNE Hold
- Analyst Count
- AXSM 17
- HLNE 6
- Target Price
- AXSM $171.65
- HLNE $160.83
- AVG Volume (30 Days)
- AXSM 672.7K
- HLNE 844.2K
- Earning Date
- AXSM 08-04-2025
- HLNE 08-05-2025
- Dividend Yield
- AXSM N/A
- HLNE 1.44%
- EPS Growth
- AXSM N/A
- HLNE 46.35
- EPS
- AXSM N/A
- HLNE 5.41
- Revenue
- AXSM $432,157,000.00
- HLNE $712,963,000.00
- Revenue This Year
- AXSM $62.57
- HLNE $0.09
- Revenue Next Year
- AXSM $59.96
- HLNE $18.35
- P/E Ratio
- AXSM N/A
- HLNE $27.80
- Revenue Growth
- AXSM 72.16
- HLNE 28.73
- 52 Week Low
- AXSM $72.21
- HLNE $123.98
- 52 Week High
- AXSM $139.13
- HLNE $203.72
- Technical
- Relative Strength Index (RSI)
- AXSM 56.52
- HLNE 46.53
- Support Level
- AXSM $108.48
- HLNE $145.13
- Resistance Level
- AXSM $114.66
- HLNE $154.07
- Average True Range (ATR)
- AXSM 3.47
- HLNE 3.70
- MACD
- AXSM 0.87
- HLNE 1.09
- Stochastic Oscillator
- AXSM 64.95
- HLNE 40.96
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HLNE Hamilton Lane Incorporated
Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.